In a May publication in iScience, researchers led by Ludwig Johns Hopkins's Ashley Cook, Nicolas Wyhs, Kenneth Kinzler and Shibin Zhou described their creation of a panel of isogenic—or genetically identical—cell lines ...
Sep 20, 2022
0
4
Researchers at Vanderbilt University Medical Center have discovered a potential new target in the fight against colorectal cancer, the nation's third most common malignancy and, next to lung cancer, the second leading cancer ...
Jul 28, 2022
0
10
Proteins that are frequently altered in tumors play a prominent role in cancer research. The protein RFX7, a largely unknown transcription factor, has recently been linked to lymph node cancer. Researchers at the Leibniz ...
Jul 19, 2022
0
7
Cancer cells can have thousands of mutations in their DNA. However, only a handful of those actually drive the progression of cancer; the rest are just along for the ride.
Jun 20, 2022
0
778
A team of researchers at the University of Michigan Rogel Cancer Center were the first to generate a bona fide mouse model of a Merkel cell carcinoma, a rare and potentially aggressive form of skin cancer. The study outlining ...
Jun 15, 2022
0
11
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
May 20, 2022
0
85
Nearly three decades after first discovering the tumor-suppressing Par-4 "super gene" that has been shown to kill cancer cells, a team of researchers at the University of Kentucky Markey Cancer Center is now learning about ...
May 16, 2022
0
84
A new study published today in the journal Genes & Development reveals a gene that normally suppresses the formation of tumors but is reprogrammed at the onset of acute promyelocytic leukemia (APL), an aggressive type of ...
Apr 20, 2022
0
41
Australian researchers have discovered a new neurodevelopmental disorder after uncovering its link to a tumor suppressor gene.
Apr 7, 2022
0
56
A team of researchers from Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) has reprogrammed the tumor microenvironment of liver cancer by using mRNA nanoparticles. This technology, similar to the ...
Feb 9, 2022
0
465
